TactiCath Contact Force Ablation Catheter, Sensor Enabled
St Jude Medical · Decision date Dec 23, 2025
What did the FDA approve?
FDA records P130026/S096 as a supplement to PMA P130026, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Dec 23, 2025.
FDA approval order statement
Approval for consolidating the integrated cabling of the existing TactiCath SE ablation catheters and introducing a non-sterile, reusable cable in place of the current design.
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 23, 2025
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P130026/S096
- Regulatory pathway
- PMA supplement
- Applicant
- St Jude Medical
- Product code
- OAE
- Decision code
- APPR
- Decision date
- Dec 23, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.
- Applicant
- St Jude Medical
- Product code
- OAE
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P130026/S096 received
Application receipt date recorded by FDA.
P130026/S096 · FDA decision
Real-Time Process
P130026/S097 · Related supplement
TactiCath Contact Force Ablation Catheter, Sensor Enabled (TactiCath SE)
P130026/S098 · Related supplement
TactiCath Sensor Enabled
P130026/S099 · Related supplement
TactiCath CF Ablation Catheter, Sensor Enabled (A-TCSE-D; A-TCSE-F; A-TCSE-J; A-TCSE-DD; A-TCSE-DF; A-TCSE-FF; A-TCSE-
P130026/S101 · Related supplement
TactiCath Ablation Catheter, Sensor Enabled (TactiCath SE)
P130026/S100 · Related supplement
TactiCath Contact Force Ablation Catheter, Sensor Enabled
P130026/S102 · Related supplement
TactiSys Quartz Equipment; Ampere Generator
Timeline entries are records held by MedtechLedger for P130026. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P130026
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| St Jude Medical | PMA supplement | Jan 8, 2026 | FDA | |
TactiCath Sensor EnabledP130026/S098 | St Jude Medical | PMA supplement | Jan 15, 2026 | FDA |
| St Jude Medical | PMA supplement | May 15, 2026 | FDA | |
| St Jude Medical | PMA supplement | May 29, 2026 | FDA | |
| St Jude Medical | PMA supplement | Jun 5, 2026 | FDA | |
TactiSys Quartz Equipment; Ampere GeneratorP130026/S102 | St Jude Medical | PMA supplement | Aug 7, 2026 | FDA |
Explore the linked device profile
Other records with product code OAE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
STOP Persistent AFP100010/S154 | Medtronic Cryocath, LP | PMA supplement | Sep 25, 2026 | FDA |
TactiFlex Ablation Catheter, Sensor EnabledP220013/S034 | ABBOTT MEDICAL | PMA supplement | Sep 22, 2026 | FDA |
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
QDOT MICRO SystemP210027/S018 | Biosense Webster, Inc. | PMA supplement | Sep 10, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
St Jude Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One St. Jude Medical Dr., St. Paul, MN, 55117
Sources and methodology
- Original FDA record: P130026/S096
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



